Higher RUNX1 expression was linked with poor DSS in GBM, LGG, KIRC, OV, MESO, and UVM, whereas increased RUNX1 expression predicted favorable DSS in SKCM, THYM, and BRCA (all p<0.05, Figure 5A–5I). The gene discussed is RUNX1; the disease is glioblastoma.